Hydreight Technologies Announces Timing of Q1 2026 Financial Results and Investor Webcast
Rhea-AI Summary
Hydreight Technologies (OTCQB: HYDTF) will release its Q1 2026 financial results after market close on Monday, June 1, 2026. Management will host an investor webcast and conference call on Tuesday, June 2, 2026 at 6:00 a.m. PT / 9:00 a.m. ET.
The webcast, led by CEO Shane Madden, will cover Q1 2026 results, business operations, VSDHOne platform growth, onboarding momentum, operating leverage, new healthcare verticals, pharmacy financing initiatives, and the company’s 2026 growth strategy and outlook. A replay will be available.
Positive
- None.
Negative
- None.
News Market Reaction – VSQTF
In the May 26 session, VSQTF declined 1.98%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 01 | Q3 2025 earnings | Positive | +24.2% | Reported Q3 2025 revenue growth, higher gross margin, and strong cash/liquidity. |
| Aug 29 | Q2 2025 earnings | Positive | +0.7% | Strong Q2 2025 results with higher six‑month adjusted revenue and Hydreight profitability. |
| Jul 09 | Q1 2025 earnings | Neutral | -2.8% | Q1 2025 results with growing revenue, solid cash, and portfolio monetizations. |
| Aug 30 | Q2 2024 earnings | Neutral | -2.9% | Q2 2024 revenue growth and higher gross margin but a net loss from write‑downs. |
| May 31 | Q1 2024 earnings | Neutral | +1.5% | Q1 2024 revenue increase, stable gross margin, and diversified portfolio updates. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings and financial updates have often triggered meaningful but mixed reactions, with several positive result reports followed by modest single-day moves and an average same-tag move of about 4.17%.
Recent history for VSQTF centers on recurring earnings and portfolio updates. Q1–Q3 2025 results highlighted rising adjusted and GAAP revenue, improving gross margins, and strong contributions from Hydreight’s healthcare platform. Some quarters, such as Q3 2025 on Dec 1, 2025, saw strong positive reactions, while others produced smaller or negative moves. Against this backdrop, the current announcement strictly schedules Q1 2026 results and an investor webcast, fitting into the established cadence of regular financial disclosures.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Management will host an investor webcast and conference call on Tuesday, June 2, 2026 at 6:00 a.m. Pacific Time / 9:00 a.m. Eastern Time to discuss the Company's Q1 2026 financial results and provide an update on business operations, platform growth, and strategic initiatives.
Topics expected to be discussed include continued growth across the VSDHOne platform, onboarding momentum, operating leverage, expansion into new healthcare verticals, pharmacy financing initiatives, and the Company's broader growth strategy and outlook for 2026.
The webcast will be hosted by Shane Madden, Chief Executive Officer of Hydreight Technologies.
Webcast Details
Date: Tuesday, June 2, 2026
Time: 6:00 a.m. PST / 9:00 a.m. EST
Webcast Registration: https://hydreight.zoom.us/webinar/register/WN_wc4MfQOrT-eXtBMuLc3gTA
A replay of the webcast will be made available following the event.
On behalf of the Board of Directors
Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.
About Hydreight Technologies Inc.
Hydreight Technologies Inc is building one of the largest mobile clinic networks in
About VSDHOne - Direct to Consumer Platform
Developed in partnership with Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FWB: 6F6), Hydreight Technologies launched the VSDHOne platform. VSDHOne simplifies the entry challenges for companies and medi-spa businesses to enter the online healthcare space compliantly. This platform is expected to help businesses launch direct-to-consumer healthcare brand in a matter of days in all 50 states. Compliant offerings include: GLP-1s, peptides, personalized healthcare treatments, sermorelin, testosterone replacement therapy ("TRT"), hair loss, skincare, sexual health and more. Hydreight invested in technology, legal and infrastructure to launch this platform. The VSDHOne platform offers a complete, and modular end-to-end solution for businesses looking to launch direct-to-consumer healthcare brands. From compliance and telemedicine technology to nationwide doctor and pharmacy networks, VSDHOne provides all the tools needed for a seamless entry into the online healthcare space. The platform is designed to significantly reduce the time and costs associated with launching such services, making it possible for businesses to go live in days instead of months.
Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Information
This press release contains statements which constitute "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding expectations for the Company's 2026 strategic outlook, growth, platform scaling initiatives, the timing, completion, and filing of the Company's financial statements and related regulatory disclosure, and anticipated expansion of VSDHOne and other platform offerings. Forward‑looking information is based on management's expectations, estimates and assumptions as of the date hereof, including assumptions regarding: the Company's ability to complete its financial reporting and audit processes in a timely manner, continued partner adoption, stable regulatory regimes applicable to telehealth and pharmacy operations in
Investors are cautioned that forward-looking information is not based on historical facts but instead reflects the Company's management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company.
Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the risk that the Company is unable to file its required financial statements and related disclosure within the time periods prescribed by applicable securities laws; potential delays in the preparation, audit, or review of financial information; the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Company's shares on the TSXV on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/hydreight-technologies-announces-timing-of-q1-2026-financial-results-and-investor-webcast-302781528.html
SOURCE Hydreight Technologies Inc.